Anikó Lovik
Universitair docent
- Naam
- Dr. A. Lovik
- Telefoon
- +31 71 527 2727
- a.lovik@fsw.leidenuniv.nl
- ORCID iD
- 0000-0002-6397-5011
Anikó Lovik is universitair docent bij de afdeling Methodologie & Statistiek.
Meer informatie over Anikó Lovik
Anikó Lovik is universitair docent bij de afdeling Methodologie & Statistiek.
Universitair docent
- Faculteit der Sociale Wetenschappen
- Instituut Psychologie
- Methodologie & Statistiek
- Chourpiliadis C., Zeng Y., Lovik A., Wei D., Valdimarsdóttir U.A., Song H., Hammar N. & Fang F. (2024), Metabolic profile and long-term risk of depression, anxiety, and stress-related disorders, Jama Network Open 7(4): e244525.
- Yazdani S., Lovik A., Seitz C., Ingre C., Fang F. & Andersson J. (2024), T cell subset composition differs between blood and cerebrospinal fluid in amyotrophic lateral sclerosis, Clinical Immunology 265: 110270.
- Chourpiliadis C, Seitz C., Lovik A., Joyce E. E., Pan L., Hu Y., Kläppe U., Samuelsson K., Press R., Ingre C. & Fang F. (2024), Lifestyle and medical conditions in relation to ALS risk and progression — : an introduction to the Swedish ALSrisc Study, Journal of Neurology 271: 5447-5459.
- Öijerstedt L., Foucher J., Lovik A., Yazdani S., Juto A., Kläppe U., Fang F. & Ingre C. (2024), Repeated cognitive assessments show stable function over time in patients with ALS, Journal of Neurology 271: 5267-5274.
- Barker M.M., Kõiv K., Magnúsdóttir I., Milbourn H., Wang B., Du X., Murphy G., Herweijer E., Gísladóttir E.U., Li H., Lovik A., Kähler A.K., Campbell A., FeychtingM., Hauksdóttir A., Joyce E.E., Thordardottir E.B., Frans E.M. Hoffart A., Mägi R., Tómasson G., Ásbjörnsdóttir K., Jakobsdóttir J., Andreassen O.A., Sullivan P.F., Johnson S.U., Aspelund T., Brandlistuen R.E., Ask H, McCartney D.L., Ebrahimi O.V., Lehto K., Valdimarsdóttir U.A., Nyberg F. & Fang F. (2024), Mental illness and COVID-19 vaccination: a multinational investigation of observational and; register-based data, Nature Communications 15: 8124.
- Foucher J., Öijerstedt L., Lovik A., Sun J., Ismail M., Sennfält S., Savitcheva I., Estenberg U., Pagani M., Fang F., Pereira. J.B. & Ingre C. (2024), ECAS correlation with metabolic alterations on FDG-PET imaging in ALS, Amyotrophic lateral sclerosis & frontotemporal degeneration 25(7-8): 708-716.
- Lovik A., González-Hijón J., Hoffart A., Fawns-Ritchie C., Magnúsdóttir I., Lu L., Unnarsdóttir Bára A., Kähler A. K., Campbell A., Hauksdóttir A., Chourpiliadis C., McCartney D.L., Thordardóttir E.B., Joyce E.E., Frans E.M., Jakobsdóttir J., Trogstad L., Andreassen O.A. Magnus P., Johnson S.U.,Sullivan P.F., Aspelund T., Porteous D.J., Ask H., Ebrahimi O.V., Valdimarsdóttir A.U. & Fang F. (2023), Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients : an observational study of five cohorts across four countries, The Lancet Regional Health Europe : .
- Foucher J., Winroth I., Lovik A., Sennfält S., Pereira J.B., Fang F., Lule D., Andersen P.M. & Ingre C. (2023), Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS), Amyotrophic lateral sclerosis & frontotemporal degeneration 24(7-8): 713-718.
- Kläppe U., Sennfält S., Lovik A., Finn A., Bofaisal U., Zetterberg H., Blennow K., Piehl F., Kmezic I., Press R., Samuelsson K., Månberg A., Fang F. & Ingre C. (2023), Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis & frontotemporal degeneration 25(1-2): 150-161.
- Shen Q., Joyce E.E., Ebrahimi O.V., Didriksen M., Lovik A., Sævarsdóttir K.S., Magnúsdóttir I., Mikkelsen D.H., Unnarsdóttir A.B., Hauksdóttir A., Hoffart A., Kähler A.K., Thórdardóttir E.B., Eythórsson E., Frans E.M., Tómasson G., Ask H., Hardardóttir H., Jakobsdóttir J., Lehto K., Lu L., Andreassen O.A., Sullivan P.F., Pálsson R., Erikstrup C., Ostrowski S.R., Werge T., Aspelund T., Pedersen O.B.V., Johnson S.U., Fang F. & Valdimarsdóttir U.A. (2023), COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark, The Lancet Regional Health Europe 35: 1-12 (e100756).
- Affiliated researcher